bf/NASDAQ:EGRX_icon.png

NASDAQ:EGRX

Eagle Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.96

01/05 20:00

Market Cap

78.44M

Beta: 0.91

Volume Today

470

Avg: 153.65K

PE Ratio

4.72

PFCF: −7.76

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Mar '23
asset turnover
0.53
-
0.89
66.93%
0.88
1.21%
0.89
2.00%
0.77
13.92%
0.74
3.61%
0.68
8.85%
0.78
15.30%
cash conversion cycle
403.67
-
2.23
99.45%
39.19
1,653.71%
104.26
166.05%
96.06
7.86%
113.85
18.52%
134.95
18.53%
194.24
43.94%
cash per share
5.19
-
3.40
34.43%
7.59
123.26%
5.34
29.73%
7.98
49.60%
7.65
4.13%
7.48
2.21%
4.28
42.84%
company equity multiplier
1.38
-
1.41
2.39%
1.51
6.74%
1.48
1.55%
1.42
4.28%
1.36
4.19%
1.44
5.64%
1.74
20.94%
days of inventory outstanding
350.89
-
18.08
94.85%
32.67
80.71%
48.95
49.86%
39.35
19.61%
64.83
64.73%
189.58
192.44%
183.75
3.07%
days of payables outstanding
91.98
-
97.12
5.59%
76.47
21.26%
58.46
23.55%
32.74
44.00%
50.32
53.71%
142.18
182.56%
73.02
48.64%
days of sales outstanding
144.77
-
81.28
43.86%
82.99
2.11%
113.76
37.08%
89.44
21.38%
99.35
11.07%
87.55
11.87%
83.51
4.62%
dividend yield
ebit per revenue
0.04
-
0.28
628.40%
0.31
11.02%
0.17
45.08%
0.11
35.12%
0.13
20.75%
-0.02
112.63%
0.17
1,094.25%
ebt per ebit
1.01
-
1.00
0.40%
0.99
1.55%
0.93
5.71%
1.01
8.48%
0.90
10.95%
1.56
73.87%
1.15
26.39%
effective tax rate
0.00
-
-0.52
45,107.78%
0.29
154.89%
0.06
78.21%
0.35
456.96%
0.47
34.91%
-0.90
290.29%
0.42
146.81%
enterprise value multiple
492.51
-
22.82
95.37%
9.33
59.14%
11.15
19.52%
25.74
130.94%
18.71
27.31%
699.54
3,638.19%
5.88
99.16%
fixed asset turnover
30.03
-
57.14
90.25%
34.71
39.26%
88.99
156.40%
88.96
0.03%
90.42
1.64%
104.86
15.97%
271.07
158.51%
free cash flow per share
-0.76
-
2.09
375.23%
3.56
69.96%
3.54
0.56%
4.01
13.45%
3.62
9.91%
2.14
40.89%
3.91
82.75%
gross profit margin
0.76
-
0.71
7.28%
0.76
7.10%
0.71
6.42%
0.69
2.90%
0.76
9.98%
0.75
0.50%
0.70
7.16%
interest coverage
232.73
-
6.67K
2,765.53%
65.13
99.02%
13.38
79.45%
8.12
39.31%
9.80
20.66%
-1.78
118.18%
13.21
841.72%
inventory turnover
1.04
-
20.19
1,841.13%
11.17
44.66%
7.46
33.27%
9.27
24.39%
5.63
39.29%
1.93
65.80%
1.99
3.17%
long term debt to capitalization
0.19
-
0.19
0.73%
0.16
17.76%
0.14
14.26%
0.02
88.03%
0.19
1,098.17%
net income per ebt
1.00
-
1.52
52.63%
0.71
53.29%
0.94
31.62%
0.65
30.58%
0.53
18.75%
1.90
258.79%
0.58
69.41%
net profit margin
0.04
-
0.43
1,007.32%
0.22
48.95%
0.15
31.84%
0.07
51.15%
0.06
12.63%
-0.05
178.78%
0.11
323.85%
operating cash flow per share
-0.64
-
3.43
637.52%
3.90
13.89%
3.55
9.08%
4.07
14.76%
3.67
9.80%
2.16
41.11%
3.92
81.30%
operating cycle
495.65
-
99.35
79.95%
115.66
16.41%
162.72
40.69%
128.80
20.84%
164.18
27.47%
277.13
68.80%
267.26
3.56%
operating profit margin
0.04
-
0.28
628.40%
0.31
11.02%
0.17
45.08%
0.11
35.12%
0.13
20.75%
-0.02
112.63%
0.17
1,094.25%
payables turnover
3.97
-
3.76
5.29%
4.77
27.00%
6.24
30.81%
11.15
78.58%
7.25
34.94%
2.57
64.61%
5.00
94.71%
pretax profit margin
0.04
-
0.28
625.47%
0.31
9.29%
0.16
48.22%
0.11
29.63%
0.12
7.53%
-0.03
121.96%
0.19
831.88%
price fair value
14.97
-
8.15
45.55%
4.50
44.74%
3.70
17.82%
4.61
24.61%
3.38
26.82%
3.77
11.58%
1.62
57.02%
receivables turnover
2.52
-
4.49
78.11%
4.40
2.06%
3.21
27.05%
4.08
27.19%
3.67
9.97%
4.17
13.47%
4.37
4.84%
return on assets
0.02
-
0.38
1,748.42%
0.19
49.57%
0.13
30.48%
0.06
57.95%
0.05
15.79%
-0.03
171.80%
0.09
358.10%
return on capital employed
0.03
-
0.31
986.08%
0.33
7.93%
0.18
44.58%
0.10
45.07%
0.12
16.10%
-0.02
113.83%
0.18
1,215.39%
return on equity
0.03
-
0.54
1,792.66%
0.29
46.17%
0.20
31.56%
0.08
59.75%
0.06
19.32%
-0.05
175.86%
0.15
412.13%
total debt to capitalization
-0.00
-
0.21
-
0.22
2.79%
0.18
18.18%
0.17
6.11%
0.14
16.34%
0.21
51.70%

All numbers in USD (except ratios and percentages)